DIAPHRAGMATIC STRENGTHENING EXERCISES FOR PATIENTS WITH POST COVID-19 CONDITION AFTER MILD-TO-MODERATE ACUTE COVID-19 INFECTION: A RANDOMIZED CONTROLLED STUDY

被引:0
|
作者
Abo Elyazed, Tamer I. [1 ]
Abd El Moneim Abd El Hakim, Ahmed [2 ]
Saleh, Ola I. [3 ]
Mostafa Fadel Sonbol, Marwa [3 ]
Eid, Hoda Assad [4 ]
Moazen, Eman M. [4 ]
Alhassoon, Mohammad Hamad [5 ]
Ezzat Fathy Elfeky, Seham [6 ]
机构
[1] Beni Suef Univ, Fac Phys Therapy, Phys Therapy Internal Med Dept, Ben Suef, Egypt
[2] Beni Suef Univ, Fac Phys Therapy, Basic Sci Dept, Ben Suef, Egypt
[3] Al Azhar Univ, Diagnost Radiol Dept, Cairo, Egypt
[4] Al Azhar Univ, Chest Dis Dept, Cairo, Egypt
[5] King Fahd Specialist Hosp, Internal Med Dept, Burydah, Saudi Arabia
[6] Tanta Univ, Chest Dis Dept, Tanta, Egypt
关键词
post COVID-19 condition; incentive spirometry; deep breathing; RESPIRATORY MUSCLE STRENGTH; INCENTIVE SPIROMETRY; PULMONARY-FUNCTION; QUALITY; DYSPNEA;
D O I
10.2340/jrm.v56.25491
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To assess the clinical effects of incentive spirometry (IS) and diaphragmatic breathing (DB) in patients with post COVID-19 condition and diaphragmatic dysfunction as compared with the standard care alone. Methods: The present longitudinal randomized study included 60 patients with post COVID-19 condition and diaphragmatic dysfunction. Patients were equally randomized to receive standard care plus IS (G1), standard care plus DB (G2) or standard care alone (G3) for 8 weeks. The primary outcome is clinical improvement as evaluated by the modified Medical Research Council (mMRC) dyspnoea scale. Results: Comparison between the studied groups revealed significant improvement in G1 and G2 in all parameters at the end of follow-up. However, no significant improvement was found in G3. At the end of follow-up, 15 patients (75.0%) in G1, 11 patients (55.0%) in G2, and 3 patients (15.0%) in G3 showed improvement on the mMRC dyspnoea scale. Multivariate logistic regression analysis identified mild acute COVID-19 infection ( p = 0.009), use of IS ( p < 0.001), and use of DB ( p = 0.023) as significant predictors of improvement on the mMRC dyspnoea scale. Conclusions: IS or DB training in addition to the standard care in post COVID-19 condition was associated with better clinical improvement as compared with the standard care alone.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Mild-to-Moderate Croup Presentations in Patients With COVID-19 Infection
    Mathew, Danica
    Calderon, Jose Cucalon
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [2] Mild-to-Moderate COVID-19 Infection and Myocarditis: A Review
    Bailey, Eric
    Frishman, William H. H.
    [J]. CARDIOLOGY IN REVIEW, 2023, 31 (03) : 173 - 175
  • [3] A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19
    Kota Iwahori
    Takuro Nii
    Norihiko Yamaguchi
    Takahiro Kawasaki
    Satomi Okamura
    Kazuki Hashimoto
    Takanori Matsuki
    Kazuyuki Tsujino
    Keisuke Miki
    Akio Osa
    Sho Goya
    Kinya Abe
    Masahide Mori
    Yoshito Takeda
    Tomomi Yamada
    Hiroshi Kida
    Atsushi Kumanogoh
    [J]. Scientific Reports, 13
  • [4] A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19
    Iwahori, Kota
    Nii, Takuro
    Yamaguchi, Norihiko
    Kawasaki, Takahiro
    Okamura, Satomi
    Hashimoto, Kazuki
    Matsuki, Takanori
    Tsujino, Kazuyuki
    Miki, Keisuke
    Osa, Akio
    Goya, Sho
    Abe, Kinya
    Mori, Masahide
    Takeda, Yoshito
    Yamada, Tomomi
    Kida, Hiroshi
    Kumanogoh, Atsushi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Azithromycin for mild-to-moderate COVID-19
    Patel, Jigar
    Berezowski, Ivan
    Abdelmonem, Ahmed
    Taylor, Dania
    Pourmand, Ali
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E99 - E99
  • [6] Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
    Mancilla-Galindo, Javier
    Kammar-Garcia, Ashuin
    Mendoza-Gertrudis, Maria de Lourdes
    Garcia Acosta, Javier Michael
    Nava Serrano, Yanira Saralee
    Santiago, Oscar
    Torres Vasquez, Miriam Berenice
    Martinez Martinez, Daniela
    Fernandez-Urrutia, Liliana Aline
    Robledo Pascual, Julio Cesar
    Narvaez Morales, Ivan Daniel
    Velasco-Medina, Andrea Aida
    Mancilla-Ramirez, Javier
    Figueroa-Damian, Ricardo
    Galindo-Sevilla, Norma
    [J]. FRONTIERS IN MEDICINE, 2023, 10
  • [7] Efficacy of Quinine Sulfate in Patients with Mild-To-Moderate COVID-19: A Randomized Controlled Trial
    Latarissa, Irma Rahayu
    Barliana, Melisa Intan
    Meiliana, Anna
    Sormin, Ida Paulina
    Sugiono, Erizal
    Kartasasmita, Cissy Bana
    Irmansyah
    Lestari, Keri
    [J]. INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (06): : 366 - 374
  • [8] Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
    Lechien, Jerome R.
    Chiesa-Estomba, Carlos M.
    Cabaraux, Pierre
    Mat, Quentin
    Huet, Kathy
    Harmegnies, Bernard
    Horoi, Mihaela
    Le Bon, Serge Daniel
    Rodriguez, Alexandra
    Dequanter, Didier
    Hans, Stephane
    Crevier-Buchman, Lise
    Hochet, Baptiste
    Distinguin, Lea
    Chekkoury-Idrissi, Younes
    Circiu, Marta
    El Afia, Fahd
    Barillari, Maria Rosaria
    Cammaroto, Giovanni
    Fakhry, Nicolas
    Michel, Justin
    Radulesco, Thomas
    Martiny, Delphine
    Lavigne, Philippe
    Jouffe, Lionel
    Descamps, Geraldine
    Journe, Fabrice
    Trecca, Eleonora M. C.
    Hsieh, Julien
    Delgado, Irene Lopez
    Calvo-Henriquez, Christian
    Vergez, Sebastien
    Khalife, Mohamad
    Molteni, Gabriele
    Mannelli, Giuditta
    Cantarella, Giovanna
    Tucciarone, Manuel
    Souchay, Christel
    Leich, Pierre
    Ayad, Tareck
    Saussez, Sven
    [J]. JOURNAL OF VOICE, 2022, 36 (02) : 249 - 255
  • [9] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
    Moser, Carlee B.
    Li, Jonathan Z.
    Hughes, Michael D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (16): : 1533 - 1535
  • [10] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
    Cao, Bin
    Wang, Yeming
    Lu, Hongzhou
    Huang, Chaolin
    Yang, Yumei
    Shang, Lianhan
    Chen, Zhu
    Jiang, Rongmeng
    Liu, Yihe
    Lin, Ling
    Peng, Ping
    Wang, Fuxiang
    Gong, Fengyun
    Hu, Honglin
    Cheng, Cong
    Yao, Xiangyang
    Ye, Xianwei
    Zhou, Hourong
    Shen, Yinzhong
    Liu, Chenfan
    Wang, Chunying
    Yi, Zhennan
    Hu, Bijie
    Xu, Jiuyang
    Gu, Xiaoying
    Shen, Jingshan
    Xu, Yechun
    Zhang, Leike
    Fan, Jia
    Tang, Renhong
    Wang, Chen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (03): : 230 - 241